Reply to 'sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA'

Journal of Analytical Toxicology

Volumn 40, Issue 3, 2016, Pages 240-242

  Angerer, Verena ^a,b   Franz, Florian ^a,b   Schwarze, Bernd ^c   Moosmann, Bjoern ^a   Auwärter, Volker ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABINOID; CANNABINOID 1 RECEPTOR; METHYL 2 [1 (CYCLOHEXYLMETHYL) 1H INDOLE 3 CARBOXAMIDO] 3,3 DIMETHYLBUTANOATE; UNCLASSIFIED DRUG;

BLOOD SAMPLING; CARDIOVASCULAR SYSTEM; DRUG BLOOD LEVEL; FORENSIC SCIENCE; HUMAN; LETTER; MASS SPECTROMETER; PLASMA PROTEIN BINDING; SUDDEN CARDIAC DEATH; RISK FACTOR; SUDDEN DEATH;

CANNABINOIDS; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; HUMANS; RISK FACTORS;

EID: 84963720850     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkw004     Document Type: Letter

References (12)

1. Westin, A.A., Frost, J., Brede, W.R., Gundersen, P.O.M., Einvik, S., Aarset, H. et al. (2015) Sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA. Journal of Analytical Toxicology, September 9, 2015: 10. 1093/jat/bkv110.
2. Angerer, V., Moosmann, B., Franz, F., Auwärter, V. (2015) 5F-Cumyl-PINACA in 'e-liquids for electronic cigarettes-a new type of synthetic cannabinoid in a trendy product. In 53rd Annual Meeting of the International Association of Forensic Toxicologists (TIAFT), Firenze, Italy, 09.08.-04.09.2015. https://www.uniklinik-freiburg.de/fileadmin/media pool/08_institute/rechtsmedizin/pdf/Poster_2015/Angerer_V_-_5F-cumyl-PINACA_in_e-liquids_for_electronic_cigarettes_-_2015.pdf (accessed Dec 04, 2015).
3. European Monitoring Centre for Drugs and Drug Addiction. (2015) EMCDDA-Europol 2014 Annual Report on the Implementation of Council Decision 2005/387/JHA. Implementation reports. Publications Office of the European Union, Luxembourg.
4. Hermanns-Clausen, M., Kneisel, S., Hutter, M., Szabo, B., Auwärter, V. (2013) Acute intoxication by synthetic cannabinoids-four case reports. Drug Testing and Analysis, 5, 790-794.
5. Hermanns-Clausen, M., Kneisel, S., Szabo, B., Auwärter, V. (2012) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108, 534-544.
6. Fantegrossi, W.E., Moran, J.H., Radominska-Pandya, A., Prather, P.L. (2014) Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity? Life Sciences, 97, 45-54.
7. Hruba, L., Ginsburg, B.C., McMahon, L.R. (2012) Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by delta(9)-tetrahydrocannabinol treatment in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 342, 843-849.
8. Gerostamoulos, D., Beyer, J., Staikos, V., Tayler, P., Woodford, N., Drummer, O. (2012) The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens. Forensic Science, Medicine, and Pathology, 8, 373-379.
9. Brents, L.K., Gallus-Zawada, A., Radominska-Pandya, A., Vasiljevik, T., Prisinzano, T.E., Fantegrossi, W.E. et al. (2012) Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochemical Pharmacology, 83, 952-961.
10. Brents, L.K., Reichard, E.E., Zimmerman, S.M., Moran, J.H., Fantegrossi, W.E., Prather, P.L. (2011) Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One, 6, e21917.
11. Rajasekaran, M., Brents, L.K., Franks, L.N., Moran, J.H., Prather, P.L. (2013) Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicology and Applied Pharmacology, 269, 100-108.
12. Chimalakonda, K.C., Seely, K.A., Bratton, S.M., Brents, L.K., Moran, C.L., Endres, G.W. et al. (2012) Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metabolism and Disposition, 40, 2174-2184.